NCT02027259: BA-MEDIC

Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits

Completed NA Last updated 15 October 2021

What this trial tests

NA trial testing Behavioral activation (BA) in Diabetes in 52 participants. Completed in 2 October 2015.

Timeline

19 January 2012

Primary endpoint
2 October 2015

2 October 2015

Quick facts

Lead sponsor	Providence VA Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	52
Start date	19 January 2012
Primary completion	2 October 2015
Estimated completion	2 October 2015
Sites	1 location across United States

Drugs / interventions tested

• Behavioral activation (BA)

Conditions studied

• Diabetes — all drugs for Diabetes →
• Depression — all drugs for Depression →

Sponsor

Providence VA Medical Center

Who can join

18 and older, any sex, with Diabetes or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether group visits with added behavioral activation (BA) for depression will have a greater clinical impact than our standard group visits without BA for depression in reducing the risk of future coronary events as measured by the United Kingdom Prospective Diabetes Study (UKPDS) risk engine and depression symptoms as measured by Patient Health Questionnaire-9 (PHQ-9) after 6 months.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Self management interventions for type 2 diabetes in adult people with severe mental illness.
   McBain H, Mulligan K, Haddad M, Flood C, et al · · 2016 · cited 34× · PMID 27120555 · DOI 10.1002/14651858.cd011361.pub2
2. Pharmacy-based management for depression in adults.
   Brown JVE, Walton N, Meader N, Todd A, et al · · 2019 · cited 19× · PMID 31868236 · DOI 10.1002/14651858.cd013299.pub2